News
Mobile Games Drive Massive Quarter For Activision Blizzard, Inc.
A slow quarter of new releases didn't slow down Activision Blizzard, Inc. (NASDAQ: ATVI) in the second quarter. The company posted much better than expected second quarter results, driven by continued
Mobile Games Drive Massive Quarter For Activision Blizzard, Inc.
A slow quarter of new releases didn't slow down Activision Blizzard, Inc. (NASDAQ: ATVI) in the second quarter. The company posted much better than expected second quarter results, driven by continued
Why Chipotle's Earnings Beat Doesn't Matter
Chipotle Mexican Grill (NYSE: CMG) shares initially spiked after the company's second quarter earnings call, as the company reported $2.32 in earnings per share, beating analysts' expectations by
Why Sarepta Therapeutics Stock Gained 10.7% in July
Sarepta Therapeutics (NASDAQ: SRPT), a biotech developing novel treatments for rare disorders, saw its shares rise by a healthy 10.7% last month, according to S&P Global Market Intelligence. The
This Bank Is About to Raise Its Dividend Nearly 30%
How does a nearly 30% dividend raise sound?It was undoubtedly music to the ears of Alabama-based Regions Financial (NYSE: RF) shareholders when they heard their bank was making such a hefty increase
Better Buy: Microsoft Corporation vs. International Business Machine Corp.
Most non-investing folks would have a hard time telling you exactly how IBM (NYSE: IBM) and Microsoft (NASDAQ: MSFT) make their money. The former used to make huge computers, and the latter makes
Better Buy: Microsoft Corporation vs. International Business Machine Corp.
Most non-investing folks would have a hard time telling you exactly how IBM (NYSE: IBM) and Microsoft (NASDAQ: MSFT) make their money. The former used to make huge computers, and the latter makes
SERGE FERRARI : DÉCLARATION DES DROITS DE VOTE AU 31 JUILLET 2017
SergeFerrari Group (FR0011950682), créateur, fabricant et distributeur de matériaux composites souples innovants, est coté sur Euronext Paris – compartiment C.
Saint Jean de Soudain, le 4....
ALPHA MOS : Informations relatives au nombre total de droits de vote
INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES....
5 Technological Innovations That Could Change the World
Image source: Getty Images.Technology is often overhyped, but sometimes there are honest-to-goodness technological innovations that have the ability to truly change the world. Consider that artificial
5 Technological Innovations That Could Change the World
Image source: Getty Images.Technology is often overhyped, but sometimes there are honest-to-goodness technological innovations that have the ability to truly change the world. Consider that artificial
5 Technological Innovations That Could Change the World
Image source: Getty Images.Technology is often overhyped, but sometimes there are honest-to-goodness technological innovations that have the ability to truly change the world. Consider that artificial
How HCP, Inc. Makes Most of Its Money
I've written before about healthcare real estate investment trust HCP, Inc. (NYSE: HCP) and how it could be a big beneficiary of the aging U.S. population over the next few decades. While I certainly
Illumina vs. Intuitive Surgical: Which Company Reported Better Earnings?
Illumina (NASDAQ: ILMN) and Intuitive Surgical (NASDAQ: ISRG) recently reported second-quarter earnings that were better than industry watchers' forecasts. These two game-changing healthcare companies
Illumina vs. Intuitive Surgical: Which Company Reported Better Earnings?
Illumina (NASDAQ: ILMN) and Intuitive Surgical (NASDAQ: ISRG) recently reported second-quarter earnings that were better than industry watchers' forecasts. These two game-changing healthcare companies
Illumina vs. Intuitive Surgical: Which Company Reported Better Earnings?
Illumina (NASDAQ: ILMN) and Intuitive Surgical (NASDAQ: ISRG) recently reported second-quarter earnings that were better than industry watchers' forecasts. These two game-changing healthcare companies
PayPal Has Plenty of Dancing Partners and Investors Should Be Thrilled
Investors have come to expect consistent growth from PayPal Holdings Inc (NASDAQ: PYPL) and it did not disappoint when it recently reported its third quarter results. Not only did the company surpass
PayPal Has Plenty of Dancing Partners and Investors Should Be Thrilled
Investors have come to expect consistent growth from PayPal Holdings Inc (NASDAQ: PYPL) and it did not disappoint when it recently reported its third quarter results. Not only did the company surpass
PayPal Has Plenty of Dancing Partners and Investors Should Be Thrilled
Investors have come to expect consistent growth from PayPal Holdings Inc (NASDAQ: PYPL) and it did not disappoint when it recently reported its third quarter results. Not only did the company surpass
AMC Networks Inc. Draws Strength From "Miscellaneous" Income Sources
TV content producer and distributor AMC Networks (NASDAQ: AMCX) reported second-quarter earnings early on Thursday morning. Strong domestic results outweighed weaker figures in the international
AstraZeneca plc: Buy the Dip?
AstraZeneca plc (NYSE: AZN) stock tumbled after the company announced the failure of an important clinical trial recently. Although the shares have recovered somewhat, the stock is still off by about
AstraZeneca plc: Buy the Dip?
AstraZeneca plc (NYSE: AZN) stock tumbled after the company announced the failure of an important clinical trial recently. Although the shares have recovered somewhat, the stock is still off by about
Cirrus Logic's Profit Surges, but Outlook Calls for Sales Drop
Audio-chip developer Cirrus Logic (NASDAQ: CRUS) reported its fiscal first-quarter results after the market closed on August 2. Solid double-digit revenue growth drove a surge in the bottom line, but
Why Vertex Pharmaceuticals Skyrocketed 17.8% in July
After reporting results from mid-stage trials showing its multi-drug combination therapies improved lung function in cystic fibrosis patients, Vertex Pharmaceuticals (NASDAQ: VRTX) shares surged 17.8%
Why Vertex Pharmaceuticals Skyrocketed 17.8% in July
After reporting results from mid-stage trials showing its multi-drug combination therapies improved lung function in cystic fibrosis patients, Vertex Pharmaceuticals (NASDAQ: VRTX) shares surged 17.8%